메뉴 건너뛰기





Volumn 86, Issue 1, 1992, Pages 100-110

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial

(98)  Serruys, Patrick W w,aa,ac   Rutsch, Wolfgang t   Danchin, Nicolas f   Wijns, William z   Emanuelsson, Hakan g   Chappuis, François e   Hermans, Walter R M w,aa,ac   Balcon, R a,aa   Timmins, J a   Springings, D C a   Brecker, S J D a   Davies, S W a   Bonnet, J L b   D'Houdain, F b   Buis, B c   Bakx, A L M c   Sedney, M I c   Campolo, L d   Danzi, G B d   de Biase, A M d   more..


Author keywords

angiotensin converting enzyme; cilazapril; clinical trials; percutaneous transluminal coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 0026766194     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.86.1.100     Document Type: Article
Times cited : (476)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.